Search research articles
Contact Us
Filters
Showing results (601-610 of 731) with videos related to
Page
of 74
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 27, 2018
Noninfectious Comorbidity in the African Cohort Study
Julie A Ake, Christina S Polyak, Trevor A Crowell, et al.
AIDS Research and Human Retroviruses
|
August 4, 2015
IgG Antibody Responses to Recombinant gp120 Proteins, gp70V1/V2 Scaffolds, and a CyclicV2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine Regimens
Nicos Karasavvas, Chitraporn Karnasuta, Hathairat Savadsuk, et al.
Plos Pathogens
|
March 18, 2022
HIV-1 infections with multiple founders associate with the development of neutralization breadth
Eric Lewitus, Samantha M Townsley, Yifan Li, et al.
The Journal of Infectious Diseases
|
January 19, 2010
A phase 1/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-Uninfected East Africans (RV 172)
Hannah Kibuuka, Robert Kimutai, Leonard Maboko, et al.
Journal of Virology
|
February 2, 2018
HIV-1 Envelope Glycoproteins from Diverse Clades Differentiate Antibody Responses and Durability among Vaccinees
Nicole L Yates, Allan C deCamp, Bette T Korber, et al.
Plos One
|
November 30, 2018
Optimizing the immunogenicity of HIV prime-boost DNA-MVA-rgp140/GLA vaccines in a phase II randomized factorial trial design
Edna O Viegas, Arne Kroidl, Patricia J Munseri, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 12, 2017
Acute Retroviral Syndrome Is Associated With High Viral Burden, CD4 Depletion, and Immune Activation in Systemic and Tissue Compartments
Trevor A Crowell, Donn J Colby, Suteeraporn Pinyakorn, et al.
The New England Journal of Medicine
|
October 22, 2009
Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand
Supachai Rerks-Ngarm, Punnee Pitisuttithum, Sorachai Nitayaphan, et al.
Plos One
|
October 29, 2014
CD8 and CD4 epitope predictions in RV144: no strong evidence of a T-cell driven sieve effect in HIV-1 breakthrough sequences from trial participants
Kalpana Dommaraju, Gustavo Kijak, Jonathan M Carlson, et al.
The Journal of Clinical Investigation
|
September 15, 2022
Durability of protection and immunogenicity of AZD1222 (ChAdOx1 nCoV-19) COVID-19 vaccine over 6 months
Magdalena E Sobieszczyk, Jill Maaske, Ann R Falsey, et al.
Page
of 74
Search research articles
Search
Showing results (601-610 of 731) with videos related to
Sort By:
Page
of 74
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 27, 2018
Noninfectious Comorbidity in the African Cohort Study
Julie A Ake, Christina S Polyak, Trevor A Crowell, et al.
AIDS Research and Human Retroviruses
|
August 4, 2015
IgG Antibody Responses to Recombinant gp120 Proteins, gp70V1/V2 Scaffolds, and a CyclicV2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine Regimens
Nicos Karasavvas, Chitraporn Karnasuta, Hathairat Savadsuk, et al.
Plos Pathogens
|
March 18, 2022
HIV-1 infections with multiple founders associate with the development of neutralization breadth
Eric Lewitus, Samantha M Townsley, Yifan Li, et al.
The Journal of Infectious Diseases
|
January 19, 2010
A phase 1/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-Uninfected East Africans (RV 172)
Hannah Kibuuka, Robert Kimutai, Leonard Maboko, et al.
Journal of Virology
|
February 2, 2018
HIV-1 Envelope Glycoproteins from Diverse Clades Differentiate Antibody Responses and Durability among Vaccinees
Nicole L Yates, Allan C deCamp, Bette T Korber, et al.
Plos One
|
November 30, 2018
Optimizing the immunogenicity of HIV prime-boost DNA-MVA-rgp140/GLA vaccines in a phase II randomized factorial trial design
Edna O Viegas, Arne Kroidl, Patricia J Munseri, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 12, 2017
Acute Retroviral Syndrome Is Associated With High Viral Burden, CD4 Depletion, and Immune Activation in Systemic and Tissue Compartments
Trevor A Crowell, Donn J Colby, Suteeraporn Pinyakorn, et al.
The New England Journal of Medicine
|
October 22, 2009
Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand
Supachai Rerks-Ngarm, Punnee Pitisuttithum, Sorachai Nitayaphan, et al.
Plos One
|
October 29, 2014
CD8 and CD4 epitope predictions in RV144: no strong evidence of a T-cell driven sieve effect in HIV-1 breakthrough sequences from trial participants
Kalpana Dommaraju, Gustavo Kijak, Jonathan M Carlson, et al.
The Journal of Clinical Investigation
|
September 15, 2022
Durability of protection and immunogenicity of AZD1222 (ChAdOx1 nCoV-19) COVID-19 vaccine over 6 months
Magdalena E Sobieszczyk, Jill Maaske, Ann R Falsey, et al.
Page
of 74